Model Medicines
PrivateLast Round
Seed
Oct 15, 2026
Total Funding Raised
$23.87M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Model Medicines operates in Healthcare & Life Sciences and is based in La Jolla, California. Its latest recorded funding round was a Seed round in October 2026.
Model Medicines is a biotechnology company that develops AI-driven drug discovery platforms and therapeutics for oncology, infectious diseases, and other therapeutic areas.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Model Medicines Comparables
Compare Model Medicines with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Passkey Therapeutics | 86% | |
| Variational AI | 86% | |
| PostEra | 84% |
For institutional investors. Book with your work email.
Model Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 15, 2026 | ||||
| Seed | Nov 14, 2025 | ||||
| Accelerator | Jun 12, 2025 | ||||
| Seed | Sep 26, 2024 | ||||
| Accelerator | May 29, 2024 | ||||
Seed | Nov 18, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Model Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Nex Cubed | Seed |
| ParticleX | Seed |
| MedTech Innovator | Accelerator |
| Irving Investors | Seed |
| Public Health Emergency Medical Countermeasures Enterprise | Accelerator |
| BioTools Innovator | Accelerator |
| 8VC | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 15, 2026
Raised $5.1M in seed funding.
- Apr 24, 2026
Monthly visitors increased 40% MoM.
For institutional investors. Book with your work email.
Model Medicines Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Model Medicines's valuation, stock price, and market status.
Is Model Medicines a public or private company?
Model Medicines is a private company.
What is the current stock price of Model Medicines?
Model Medicines is a private company, so its shares have no public market price. Caplight tracks Model Medicines's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Model Medicines worth (valuation)?
Valuation information for Model Medicines is not publicly available.
Can I buy Model Medicines stock?
Model Medicines shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Model Medicines's last funding round?
Model Medicines's most recent funding round was Seed on October 15, 2026.
Who are the main investors in Model Medicines?
Key investors in Model Medicines include Nex Cubed, ParticleX, MedTech Innovator, Irving Investors, Public Health Emergency Medical Countermeasures Enterprise.
Will Model Medicines IPO soon?
No public IPO plans have been announced for Model Medicines.
How can I track Model Medicines secondary market activity?
Caplight tracks bids, offers, and trades in Model Medicines's shares on secondary markets.